Claim CME

Public Health

Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer

Educational Objective
To identify the key insights or developments described in this article

1 Credit CME

JAMA Oncology

August 1, 2021

Research Letter

Article Information and Disclosures

Cynthia Villarreal-Garza, MD, DSc^1,2;

Bryan F. Vaca-Cartagena, MD¹;

Andrea Becerril-Gaitan, MD¹;

et al

Ana S. Ferrigno, MD¹;

Fernanda Mesa-Chavez, MD¹;

Alejandra Platas, MSc²;

Ana Platas, BA²

Author Affiliations

¹Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza García, Nuevo León, Mexico
²Médicos e Investigadores en la Lucha contra el Cáncer de Mama, Mexico City, Mexico

Read article on JAMA Network

Read Article Claim CME

The COVID-19 pandemic has had a substantial effect on cancer care.¹ The recent widespread availability of vaccines against SARS-CoV-2 is a promising strategy to prevent COVID-19–associated mortality. However, previous reports have shown a high hesitancy rate to receive a COVID-19 vaccine among oncologic patients.²^,3 Because breast cancer is the most commonly diagnosed malignant neoplasm,⁴ it is imperative to evaluate the specific concerns regarding COVID-19 vaccination among patients with this disease.

Claim CME

Buy This Activity

Article Information

Accepted for Publication: April 21, 2021.

Published Online: June 10, 2021. doi:10.1001/jamaoncol.2021.1962

Corresponding Author: Cynthia Villarreal-Garza, MD, DSc, Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, Batallón de San Patricio 112, Real de San Agustín, 66278 San Pedro Garza García, Nuevo León, Mexico (cynthia.villarreal@tecsalud.mx).

Author Contributions: Dr Villarreal-Garza had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: All authors.

Acquisition, analysis, or interpretation of data: Villarreal-Garza, Vaca-Cartagena, Becerril-Gaitan, Ferrigno, Mesa-Chavez.

Drafting of the manuscript: Villarreal-Garza, Vaca-Cartagena, Becerril-Gaitan, Ferrigno, Mesa-Chavez.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Vaca-Cartagena, Becerril-Gaitan.

Administrative, technical, or material support: Villarreal-Garza, Alejandra Platas, Ana Platas.

Supervision: Villarreal-Garza, Mesa-Chavez.

Conflict of Interest Disclosures: Dr Villarreal-Garza reported grants from AstraZeneca and Roche; speaking honoraria from Roche, Myriad Genetics, Novartis, Pfizer, and Eli Lilly; travel fees from Roche, MSD Oncology, and Pfizer; and advisory roles at Roche, Novartis, Pfizer, and Eli Lilly. No other disclosures were reported.

Additional Contributions: We thank the organizations that helped to disseminate the survey: Médicos e Investigadores en la Lucha contra el Cáncer de Mama, Salvati AC, Coalición Mexicana por la Salud Mamaria, Cáncer Warriors de México, Red Contra el Cáncer, Programa de Supervivientes del Instituto Nacional de Cancerología, Pro Oncavi, Grupo Vida Plena Después Del Cáncer AC, Fundación Unidas Contigo, and Encauza.

References

Jazieh AR , Akbulut H , Curigliano G , et al; International Research Network on COVID-19 Impact on Cancer Care. Impact of the COVID-19 pandemic on cancer care: a global collaborative study. JCO Glob Oncol. 2020;6:1428-1438. doi:10.1200/GO.20.00351 PubMed Google Scholar

Dutch Federation of Cancer Organizations. Kankerzorg in de anderhalvemeter-samenleving, wat is jouw ervaring? Accessed April 5, 2021. https://nfk.nl/nieuws/kankerzorg-in-de-anderhalvemeter-samenleving-wat-is-jouw-ervaring

Barrière J , Gal J , Hoch B , et al. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol. 2021;32(5):673-674. doi:10.1016/j.annonc.2021.01.066 PubMed Google Scholar Crossref

Sung H , Ferlay J , Siegel RL , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. Published online February 4, 2021. doi:10.3322/caac.21660 PubMed Google Scholar

Lazarus JV , Ratzan SC , Palayew A , et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225-228. doi:10.1038/s41591-020-1124-9 PubMed Google Scholar Crossref

Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer

Public Trust and Willingness to Vaccinate Against COVID-19 in the US

Lay Epidemiology and Vaccine Acceptance

Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer

Public Trust and Willingness to Vaccinate Against COVID-19 in the US

Lay Epidemiology and Vaccine Acceptance

See More About

If you are not a JN Learning subscriber, you can either:

A subscription to JN Learning (CME from JAMA Network) provides:

Sign in to access

If you are not a JN Learning subscriber, you can either:

Sign in to customize your interests

With a personal account, you can:

Name Your Search

Sign in to save your search

With a personal account, you can:

Lookup An Activity

My Saved Searches

Sign in to customize your interests

With a personal account, you can:

Purchase access